logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Barratt-johnson, Malcolm Francis
    Director born in September 1963
    Individual (10 offsprings)
    Officer
    icon of calendar 2010-09-02 ~ now
    OF - Director → CIF 0
    Mr Malcolm Francis Barratt-johnson
    Born in September 1963
    Individual (10 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

PHARMAMEDIC CONSULTANCY LIMITED

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Intangible Assets
4,756 GBP2024-09-30
3,516 GBP2023-09-30
Property, Plant & Equipment
8,374 GBP2024-09-30
8,717 GBP2023-09-30
Debtors
Current
337,466 GBP2024-09-30
280,017 GBP2023-09-30
Cash at bank and in hand
30,363 GBP2024-09-30
44,202 GBP2023-09-30
Net Assets/Liabilities
1,786 GBP2024-09-30
2,316 GBP2023-09-30
Equity
Called up share capital
100 GBP2024-09-30
100 GBP2023-09-30
Retained earnings (accumulated losses)
1,686 GBP2024-09-30
2,216 GBP2023-09-30
Equity
1,786 GBP2024-09-30
2,316 GBP2023-09-30
Average Number of Employees
42023-10-01 ~ 2024-09-30
42022-10-01 ~ 2023-09-30
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
7,206 GBP2024-09-30
5,333 GBP2023-09-30
Intangible Assets - Gross Cost
7,206 GBP2024-09-30
5,333 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
2,450 GBP2024-09-30
1,817 GBP2023-09-30
Intangible Assets - Accumulated Amortisation & Impairment
2,450 GBP2024-09-30
1,817 GBP2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
633 GBP2023-10-01 ~ 2024-09-30
Intangible Assets - Increase From Amortisation Charge for Year
633 GBP2023-10-01 ~ 2024-09-30
Intangible Assets
Patents/Trademarks/Licences/Concessions
4,756 GBP2024-09-30
3,516 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
Vehicles
14,395 GBP2024-09-30
14,395 GBP2023-09-30
Computers
8,898 GBP2024-09-30
10,198 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
23,293 GBP2024-09-30
24,593 GBP2023-09-30
Property, Plant & Equipment - Disposals
Computers
-4,240 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Disposals
-4,240 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Vehicles
9,840 GBP2024-09-30
8,322 GBP2023-09-30
Computers
5,079 GBP2024-09-30
7,554 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
14,919 GBP2024-09-30
15,876 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Vehicles
1,518 GBP2023-10-01 ~ 2024-09-30
Computers
1,218 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,736 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Computers
-3,694 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-3,694 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment
Vehicles
4,555 GBP2024-09-30
6,073 GBP2023-09-30
Computers
3,819 GBP2024-09-30
2,644 GBP2023-09-30
Trade Debtors/Trade Receivables
Current
88,178 GBP2024-09-30
44,869 GBP2023-09-30
Amount of corporation tax that is recoverable
Current
28,421 GBP2024-09-30
28,421 GBP2023-09-30
Other Debtors
Current
220,867 GBP2024-09-30
206,727 GBP2023-09-30
Bank Overdrafts
-62,792 GBP2024-09-30
-39,531 GBP2023-09-30
Bank Borrowings/Overdrafts
Current
73,441 GBP2024-09-30
50,179 GBP2023-09-30
Trade Creditors/Trade Payables
Current
29,839 GBP2024-09-30
51,170 GBP2023-09-30
Other Creditors
Current
96,199 GBP2024-09-30
100,795 GBP2023-09-30
Bank Borrowings/Overdrafts
Non-current
6,700 GBP2024-09-30
16,845 GBP2023-09-30
Other Creditors
Non-current
115,592 GBP2024-09-30
78,772 GBP2023-09-30
  • PHARMAMEDIC CONSULTANCY LIMITED
    Info
    Registered number 07364364
    icon of addressThe London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2010-09-02 (15 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-09-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.